Strata Skin Sciences, Inc. SSKN

0.01 0.00 0.00% as of 25 Sep
Market cap
$1.0M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
3.93 4.07 16.49 15.63 18.11 12.59 6.80 8.12 8.60 7.91
Receivables
3.39 3.14 3.39 4.39 2.94 3.43 4.47 4.44 5.25 4.12
Inventory
2.82 3.01 2.79 3.03 3.44 3.49 3.10 2.67 2.25 2.81
Total current assets
10.75 10.75 23.21 23.56 24.83 19.97 15.05 15.54 16.60 15.60
Property, Plant, Equpment (Net)
10.18 7.70 5.30 5.37 5.53 6.88 9.95 11.78 10.06 8.96
Goodwill and Intangible Assets (Total)
22.22 20.63 18.57 16.76 15.15 18.89 26.20 13.84 6.78 4.81
Long-term assets (Other)
0.05 0.05 0.43 0.35 0.28 0.22 0.10 0.23 0.23 0.23
Total non-current assets
32.44 28.38 24.30 23.79 21.95 26.62 37.22 26.47 18.33 14.92
Total Assets
43.19 39.13 47.51 47.34 46.78 46.59 52.27 42.02 34.93 30.52
Notes Payable
0.34 0.36 — 7.28 7.28 — — — — —
Accounts Payable
1.85 2.28 1.76 1.88 2.76 2.82 3.43 3.34 2.43 2.76
Accrued Expenses
— 3.58 4.50 5.13 4.69 6.38 6.56 6.31 7.36 6.16
Current Part of Debt
1.71 2.39 0.25 7.59 1.48 0.32 0.36 — — 15.35
Current Revenue (Deferred)
0.24 1.87 2.10 2.83 2.26 3.29 2.78 2.12 2.24 2.25
Other current liabilities
1.99 3.33 3.88 4.77 3.85 9.66 0.31 0.05 1.03 —
Total current liabilities
6.13 10.47 8.62 17.43 18.84 12.80 13.43 12.17 13.40 26.74
Long Term Debt (Total)
21.78 7.85 7.15 1.08 1.05 7.32 7.48 15.04 15.19 —
Non-current Revenue (Deferred)
— — 0.27 0.12 0.03 0.40 0.31 0.55 0.35 0.18
Long Term Tax Liability (Deferred)
0.36 0.41 0.11 (0.11) 0.25 0.27 0.31 0.19 — —
Non-current Liabilities (Other)
0.20 0.51 0.39 0.18 0.03 0.39 8.31 1.14 0.10 —
Total non-current liabilities
22.34 8.78 7.64 1.26 2.05 8.38 17.02 17.15 16.56 0.87
Total liabilities
28.47 19.25 16.26 18.69 20.89 21.18 30.44 29.33 29.96 27.61
Additional Paid In Capital
225.29 223.83 241.99 243.18 244.83 247.06 249.02 250.74 253.11 257.31
Preferred Stock (Total)
0.00 0.00 0.00 0.00 — — — — — —
Common Stock (Net)
0.00 0.00 0.03 0.03 0.03 0.03 0.04 0.00 0.00 0.01
Retained Earnings
(210.57) (203.96) (210.77) (214.56) (218.97) (221.68) (227.23) (238.06) (248.14) (254.40)
Common Equity (Total)
14.72 19.88 31.25 28.65 25.89 25.41 21.83 12.69 4.97 2.91
Shareholders Equity (Total)
14.72 19.88 31.25 28.65 25.89 25.41 21.83 12.69 4.97 2.91
Shareholders Equity and Liabilities (Total)
43.19 39.13 47.51 47.34 46.78 46.59 52.27 42.02 34.93 30.52
Shares (Common)
0.22 0.43 2.99 3.29 3.38 3.44 3.47 3.51 4.17 5.89
Shares (Preferred)
0.00 0.00 0.00 0.00 — — — — — —
Shareholders Equity (Tangible)
(7.50) (0.75) 12.68 11.90 10.74 6.53 (4.37) (1.15) (1.80) (1.90)
Net Debt
19.57 6.17 (9.09) (6.96) (15.58) (4.95) 1.04 6.93 6.60 7.44
Total Debt
23.49 10.24 7.40 8.67 2.53 7.64 7.83 15.04 15.19 15.35

Fold the line items

In millions of $ except per-share values · columns are period end dates